SCHEMBL27754646

SCHEMBL27754646

[CH2]CC(CC=O)c1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 1/20 0.40
GABBR2 O75899 2/20 0.37
GABBR1 Q9UBS5 2/20 0.37
CYP2D6 P10635 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.36
CYP1A2 P05177 1/20 0.36
PKM P14618 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
HTR2A P28223 3/20 0.34
HRH1 P35367 2/20 0.34
KDM4E B2RXH2 2/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
TAAR1 Q96RJ0 1/20 0.33
ALDH1A1 P00352 1/20 0.33
MAPT P10636 1/20 0.33
ALOX15 P16050 1/20 0.33
HSD17B10 Q99714 1/20 0.33
SRC P12931 1/20 0.32
MTNR1A P48039 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3140559 0.87 CYP2D6 (0.42) CYP2C19GABBR2GABBR1CYP2D6SMN1; SMN2
SCHEMBL253606 0.82 CYP2C19 (0.52) CYP2C19GABBR2GABBR1CYP2D6SMN1; SMN2
SCHEMBL1610252 0.81 CYP2C19 (0.50) CYP2C19GABBR2GABBR1CYP2D6SMN1; SMN2
SCHEMBL3031215 0.79 TAAR1 (0.43) GABBR2GABBR1CYP2D6SMN1; SMN2CYP1A2
SCHEMBL464510 0.79 CCR5 (0.45) CYP2C19GABBR2GABBR1CYP2D6SMN1; SMN2
SCHEMBL4864892 0.79 CCR5 (0.45) CYP2C19GABBR2GABBR1CYP2D6SMN1; SMN2
SCHEMBL5705436 0.79 CYP2D6 (0.41) CYP2C19GABBR2GABBR1CYP2D6SMN1; SMN2
SCHEMBL19812664 0.79 GABBR2 (0.55) CYP2C19GABBR2GABBR1CYP2D6SMN1; SMN2
SCHEMBL28192513 0.79 GABBR2 (0.37) CYP2C19GABBR2GABBR1CYP2D6SMN1; SMN2
SCHEMBL11537548 0.79 GABBR2 (0.37) CYP2C19GABBR2GABBR1CYP2D6SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101395154-B 8-azabicyclo [3.2.1] octane compounds as mu opioid receptor antagonists THERAVANCE INC 2011-01-19 CN disclosed
CN-101395154-A 8-azabicyclo [3.2.1] octane compounds as mu opioid receptor antagonists THERAVANCE INC (US) 2009-03-25 CN disclosed